✦ LIBER ✦

A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial

✍ Scribed by M. Ducreux; E. Van Cutsem; J.L. Van Laethem; T.M. Gress; K. Jeziorski; P Rougier; T. Wagener; O. Anak; B. Baron; B. Nordlinger

Book ID: 116428407
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 128 KB
Volume: 41
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2004.10.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly high-dose 5-fluorouracil and foli

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group

✍ R.E.N. Van Rijswijk; K. Jeziorski; D.J.TH. Wagener; J.-L. Van Laethem; S. Reuse; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase I and II trial of epirubicin, ci

A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas

✍ Christos S KARAPETIS; Kerry A CHEONG; Desmond YIP; Andrew H STRICKLAND; Christop 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Weekly oxaliplatin, 5-fluorouracil and f

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

✍ D Santini; F Graziano; V Catalano; M Di Seri; E Testa; AM Baldelli; P Giordani; 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 281 KB

A phase II trial of interferon alpha-2A,

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma

✍ David H. Ilson; Matthew Sirott; Leonard Saltz; Robert Heelan; Ying Huang; Roger 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

755 - A phase II trial of trimetrexate (

755 - A phase II trial of trimetrexate (TMTX), 5-fluorouracil (5-FU) and folinic acid (FA) in untreated patients with advanced colorectal carcinoma

✍ E.D. Kreuser; H. Szelenyi; P. Hohenberger; H. Lochs; N. Habboubi; W. Oster; E. T 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer